Funding for this research was provided by:
National Multiple Sclerosis Society (CA-1708-29059)
Article History
Received: 16 October 2023
Revised: 18 December 2023
Accepted: 24 December 2023
First Online: 12 January 2024
Declarations
:
: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
: The study protocol was approved by the Institutional Review Board of the University of Alabama at Birmingham (IRB-161108001). The procedures used in this study adhere to the tenets of the Declaration of Helsinki.